
UK - Sovereign reaps 11.9x return from veterinary services exit
Sovereign Capital has reaped 11.9x its money through the flotation of veterinary services consolidator CVS Group on AIM. The IPO gave CVS a market capitalisation of £105.7m.
CVS was established in August 1999 with funding from Sovereign which enabled it to commence the consolidation of the veterinary practice market. To date it has made 39 acquisitions and now comprises 45 practices nationwide together with three diagnostic laboratories. The deal returned an IRR of 52% to Sovereign over the life of the investment. In 2006/7, CVS generated an EBITDA of £5.1m on sales of £39m.
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater
Back to Top